Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • mlloyd
    Junior Member
    • Dec 2015
    • 1

    #1

    Question about how to interpret DEXSeq data with a multi-factor experimental design

    I have successfully run DEXSeq (version 1.16.7) in R version 3.2.3. I believe the analysis ran smoothly without any problems but I am having trouble interpreting the results.

    I have a multi-factor experimental design:
    Day 1/Low CO2
    Day 1/High CO2
    Day 7/Low CO2
    Day 7/High CO2

    I checked for the effect of CO2 with the following formulas:
    ~ sample + exon
    vs.
    ~ sample + exon + CO2:exon
    This resulted in 134149 insignificant hits and 3 significant hits

    I then checked for the effect of CO2 when accounting for Day with the following:
    reduced model = ~ sample + exon + Day:exon
    full model = ~ sample + exon + Day:exon + condition:exon
    This resulted in the same results as above

    I then did 4 separate tests subsetting the data:
    Effect of Day in only low CO2 data: 4,821 significant hits
    Effect of Day in only high CO2 data: 4,258 significant hits
    Effect of CO2 only in Day 1: no significant hits
    Effect of CO2 only in Day 7: no significant hits

    The large effect of Day is expected because we were sequencing early embryos that were developing very quickly. However, you can see the number of significant exons is not the same in the two tests for the effect of Day. Furthermore, when I compare the lists of the 4,821 significant hits to the list of the 4,258 significant hits, I find a lot of hits unique to each test.

    This leads me to believe there might be an interaction between CO2 and Day but I cannot figure out how to test for it. My question is: How do I test for the interacting effect between two factors in DEXSeq?

    Thanks!

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
43 views
0 reactions
Last Post SEQadmin2  
Working...